Bai YM, Yu SC, Lin CC.
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
J Clin Psychiatry. 2003;64:1342-1348.
Bradley WG, Daroff RB, Fenichel G, Jankovic J.
Neurology in Clinical Practice.
4th ed. Butterworth Heinemann; 2003. Accessed November 4, 2007.
Cecil RL, Goldman L, Bennett JC.
Cecil Textbook of Medicine. 21st ed. Philadelphia, PA: WB Saunders Co; 2000.
Conn HF, Rakel RE.
Conn's Current Therapy 2001. 53rd ed. Philadelphia, PA: WB Saunders Co; 2001.
Dambro M.
Griffith's 5-Minute Clinical Consult. Baltimore, MD: Lippincott Williams & Wilkins; 2001.
Damier P. Drug-induced dyskinesias.
Curr Opin Neurol. 2009;22(4):394-399.
Goroll A, Mulley A.
Primary Care Medicine. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V, Liu-Seifert H.
Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:985-996.
McGrath JJ, Soares KV. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Cochrane
Database Syst Rev. 2006;CD000459.
Meco G, Fabrizio E, Epifanio A, et al. Levetiracetam in tardive dyskinesia.
Clin Neuropharmacol. 2006;29:265-268.
Noble J, Greene HL.
Textbook of Primary Care Medicine. 3rd ed. St. Louis, MO: Mosby Inc; 2001.
Pham DQ, Plakogiannis R. Vitamin E supplementation in Alzheimer’s disease, Parkinson’s disease, tardive dyskinesia, and cataract: part 2.
Ann Pharmacother. 2005;39(12):2065-72.
Sachdev PS. The current status of tardive dyskinesia.
Australian and New Zealand Journal of Psychiatry. 2000;34:355-369.
Soares KV, McGrath JJ. The treatment of tardive dyskinesia: a systematic review and meta-analysis.
Izophr Res.
1999;39(1):1-16.
Tardive dyskinesia. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed/. Updated November 23, 2011. Accessed February 25, 2013.
Tardive dyskinesia. National Alliance on Mental Illness website. Available at:
http://www.nami.org/Content/ContentGroups/Helpline1/Tardive_Dyskinesia.htm. Updated September 2003. Accessed February 25, 2013.
Tasman A, Kay J, Lieberman J.
Psychiatry. Philadelphia, PA: WB Saunders Co; 1997.
Thema B, Srivastava V, Tiwari AK. Genetic underpinnings of tardive dyskinesias: passing the baton to pharmacogenetics.
Pharmacogenomics.
2008;9:1285-1306.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.